Akademisyen
FUAT BUĞRUL
DOKTOR ÖĞRETİM ÜYESİ
SELÇUK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Çocuk Endokrinolojisi (Çocuk Sağlığı ve Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 53
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
4
Q2
7
Q3
7
Q4
3
WoS (JCR)
Q1
1
Q2
5
Q3
5
Q4
10
TR Index
10
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
42.1%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Pharmacogenetic hypersensitivity to somatropin in a child with severe growth hormone deficiency and MC4R p.V166I variant OpenAlex 82.9%
- 2022 POU6F2 mutation identified in humans with pubertal failure shifts isoform formation and alters GnRH transcript expression
- 2021 Adrenocortical hormone profiles do not predict the molecular etiology in non-CAH primary adrenal insufficiency OpenAlex 16.0%
- 2021 Supplemental Table 5. Adrenal steroid hormones of non-CAH PAI patients with identified molecular etiologies compared to control group
- 2021 Supplemental Table 2.
- 2021 Supplemental Table 1. Characteristics of patients with SGPL1 mutations
- 2021 Supplemental Material: Case summaries according to molecular etiologies
- 2021 Supplemental Table 3. Comparison of clinical and biochemical characteristics of PAI patients with solved or unsolved etiology
- 2021 Supplemental Material: Case summaries according to molecular etiologies
- 2021 Supplemental Table 4. Comparison of adrenal steroids of non-CAH PAI patients with identified molecular etiologies causing isolated glucocorticoid (patients with MC2R, MRAP and NNT mutations) vs glucocorticoid+mineralocorticoid+sex steroid deficiency (patients with StAR, CYP11A1, SGPL1, ABCD1, AAAS, NR0B1/DAX1, AIRE mutations).
- 2021 Supplemental Table 5.
- 2021 Supplemental Table 2. Characteristics of PAI patients with unknown molecular etiology
- 2021 Supplemental Table 1.
- 2021 Supplemental Table 3.
- 2021 Supplemental Table 3. Comparison of clinical and biochemical characteristics of PAI patients with solved or unsolved etiology
- 2021 Supplemental Table 4.
- 2021 Supplemental Table 1. Characteristics of patients with SGPL1 mutations
- 2021 Supplemental Material: Case summaries according to molecular etiologies
- 2021 Supplemental Material: Case summaries according to molecular etiologies
- 2021 Supplemental Material: Case summaries according to molecular etiologies